Fundraising Fox

Adcendo ApS

9 known investors

adcendo.com

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

Investors · 9

Competitors · 1

by search overlap

Companies competing with Adcendo ApS for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Adcendo ApS do?
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
Who are Adcendo ApS's investors?
Adcendo ApS's investors include Vida Ventures, HealthCap, Jeito Capital, Novo Holdings, OrbiMed, Pontifax Venture Capital, RA Capital, TCG Crossover and 1 more.